11/04/2024
How are our customers using Maxwell® for cell and gene therapy?
• Biodistribution studies for adeno-associated virus (AAV) or lentivirus vector therapy development
• Viral genome titer assays in the preclinical phase and/or QC batch release processes to ensure the quality and consistency of lentiviral vectors
• In biomarker discovery, gene expression profiling or functional studies to analyse mRNA expression
• In vector integration analysis, safety and efficacy evaluation or monitoring gene therapy outcomes to look at transgene copy number
• DNA purification to support the development, study of efficacy and manufacturing of CAR-T cell therapies.
Find out more about the Maxwell and its Automated Nucleic Acid Extraction for Cell and Gene Therapy Applications at https://bit.ly/3UaFnUc